Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Timothy Squire

Timothy M. Squire

Partner Fasken
Increasing government regulation continues to put more pressure on the life sciences sector in Canada.
Jurisdiction Ontario, 1997
Language(s) English
Office(s) Toronto

Timothy Squire is Co-Chair of the firm’s International Life Sciences Industry Group. Bringing extensive regulatory and commercialization experience, Tim is a trusted advisor to both large and small drug, device, natural health product, cosmetic and food manufacturers.

Tim’s practice is devoted to the Life Sciences industry.  He adds substantial bench strength to the firm's Life Sciences Group given his extensive knowledge and experience across the entire health product lifecycle. Tim has become a trusted advisor to many many stakeholders in the drug, device, natural health product, cosmetic and food industries in Canada and around the world due to his expertise and commitment to client service.

Tim's regulatory practice covers all aspects of health product regulation, and he is one of the few specialists in Canada regularly called upon to help solve complex health product compliance and enforcement issues.  To this end, Tim frequently communicates with Health Canada and other federal and provincial regulators on our clients’ behalf.  

In addition to his regulatory expertise, Tim also negotiates and drafts sophisticated commercial arrangements for Life Sciences clients, including license agreements, distribution agreements, manufacturing and supply agreements, technology and material transfer agreements, joint R&D agreements, and funding agreements.

Tim also quarterbacks regulatory due diligence in complex domestic and cross-border transactions involving drug, medical device, natural health product, cosmetic, and food companies, and is often called upon to manage the transition of market authorizations and regulatory operations post acquisition.

Tim performs in-house legal functions for several U.S. and international clients without Canadian in-house legal or regulatory capabilities, and in this capacity has developed a comprehensive understanding of the business issues and pressures facing companies in the life sciences industry.

Tim’s expertise in the life sciences sector has been recognized by Chambers Canada, Who’s Who Legal, IAM Strategy 300: The World’s Leading IP Strategists, and he has twice received LMG’s Life Sciences Canadian Regulatory Attorney of the Year award.

  • IAM Strategy 300: The World’s Leading IP Strategists 2017
  • Chambers Canada 2017 for Life Sciences
  • Winner, Canadian Regulatory Attorney of the Year Award, LMG Life Sciences, 2015
  • Leading Lawyer in Life Sciences (Life Sciences Star), LMG Life Sciences, 2014-2015
  • Who’s Who Legal, The International Who’s Who of Life Sciences Lawyers – Regulatory, 2014
  • Who's Who Legal 100 2014-2016 for Life Sciences
  • Who's Who Legal: Canada 2014-2017 for Life Sciences
  • Winner, Canadian Regulatory Attorney of the Year Award, LMG Life Sciences, 2013


  • LLB University of Windsor
  • BA University of Windsor
Article Canadian Expert Tim Squire: Bill pushing drug imports from Canada is a roundabout solution Stat News
Article U.S. Bill to Import Canadian Drugs Gets Chilly Reception North of the Border International Trade Reporter
Getting the Deal Through: Healthcare Enforcement & Litigation 2016 (Canada)
The Regulation of Mobile Medical Apps as Medical Devices location location Toronto
The Medical Device Regulatory Framework in Canada location location Shanghai, China


    Receive email updates from our team